Related Experiment Video

Updated: Jul 16, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Neuroendocrine tumors. Peptide receptor radionuclide therapy

Flavio Forrer1, Roelf Valkema, Dik J Kwekkeboom

  • 1Department of Nuclear Medicine, Erasmus Medical Centre Rotterdam, Dr Molewaterplein 40, NL-3015 GD Rotterdam, The Netherlands.

Best Practice & Research. Clinical Endocrinology & Metabolism
|March 27, 2007
PubMed

Insights

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogues offers a promising treatment for neuroendocrine tumors. This approach shows significant tumor shrinkage in about 25% of patients with rare serious side effects.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiopharmaceutical Therapy

Background:

  • Neuroendocrine tumors (NETs) often over-express somatostatin receptors.
  • Radiolabeled somatostatin analogues are the gold standard for NET imaging and staging.
  • Targeting somatostatin receptors offers a therapeutic window for NET treatment.

Purpose of the Study:

  • To review the efficacy and safety of peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogues for unresectable, somatostatin-receptor-positive neuroendocrine tumors.
  • To discuss clinical considerations, including indications and timing of PRRT.
  • To highlight future research directions for enhancing PRRT efficacy.

Main Methods:

  • Review of clinical data on PRRT using various radiolabeled somatostatin analogues.
  • Analysis of treatment outcomes, including tumor response and adverse events.
  • Discussion of current clinical practice and future research strategies.

Main Results:

  • PRRT is an effective treatment modality for somatostatin-receptor-positive neuroendocrine tumors.
  • Objective tumor shrinkage greater than 50% was observed in approximately 25% of treated patients.
  • Serious side effects associated with PRRT were rare.

Conclusions:

  • PRRT with radiolabeled somatostatin analogues is a convincing and safe treatment option for NET patients.
  • Further research is needed to optimize PRRT strategies and improve therapeutic outcomes.
  • The review provides insights into current clinical applications and future directions for PRRT in neuroendocrine tumor management.

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...